Breaking News, Promotions & Moves

Illumina Unveils CEO Transition Plan

Charles Dadswell replaces Francis deSouza as CEO.

Illunina Inc., a company involved in DNA sequencing and array-based technologies, named Charles Dadswell interim CEO. Dadswell has been serving as senior vice president and general counsel. The company’s board of directors accepted the resignation of Francis deSouza, Sunday, June 11. deSouza will stay on in an advisory capacity until July 31, 2023. “We thank Francis for his contributions and leadership and are very excited about embarking on the next chapter of Illumina’s great...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters